Private Markets Update & Deal Flow
SpaceX turns a week-old stock into an acquisition engine, paying USD 60B in shares for Cursor just four days after closing the largest IPO in history. Washington orders Anthropic to suspend Mythos and Fable for the public, rattling allies who arrive at the G7 with sovereign AI plans already in hand. OpenAI answers with its own move, folding Ona into Codex as weekly users surge 400%. DeepSeek raises USD 7.4B and admits, in an anti-poach clause, that talent rather than capital is its real constraint. Thoma Bravo writes a USD 5B check to zero on Medallia. And Anduril does something no startup has managed in half a century: it wins a US fighter jet program.
SpaceX Exercises Its Option, Buys Cursor for USD 60B in Stock
Deal Size
+16%
on announcement day
SpaceX Stock
USD 3B
annualised, late April
Cursor ARR
~USD 2.1T
Nasdaq: SPCX
The investor read: this is the first real test of SpaceX’s freshly listed stock as acquisition currency, and Musk used it within a week of having it. Whether Cursor was worth USD 60B on fundamentals alone is almost beside the point. What matters is that SpaceX now has a credible developer-tools wedge to pair with xAI, at a moment when distribution, not raw model quality, is deciding the AI coding market.
Washington Freezes Anthropic’s Frontier Models, Mythos and Fable Go Dark
Models Suspended
public access only
June 12, 2026
Directive Date
export control basis
>USD 300B
IPO Backdrop
private valuation target
fallback for risk queries
For pre-IPO holders, the question is not whether Anthropic survives this episode; it almost certainly will. The real question is whether a precedent that treats frontier models as controlled exports becomes a permanent tax on every AI company’s addressable market, Anthropic’s included. Watch whether the restriction lifts before the roadshow begins.
G7 Leaders Confront the Anthropic Ban, and the Sovereign AI Scramble That Followed
EU Response
proposed sovereign compute package
Evian-les-Bains
Summit Venue
G7, June 17
European sovereign AI
Beneficiary
Mistral and others
aerospace · chips · autos · pharma
The export ban did in one week what years of European “strategic autonomy” rhetoric could not: it gave Mistral, and every non-US frontier lab, an unimpeachable reason for governments and enterprises to diversify away from Anthropic and OpenAI. Watch the European sovereign AI raises that follow.
OpenAI Buys Ona to Arm Codex for the Long Campaign Against Claude Code
Weekly Codex Users
up ~400% this year
2M
Developers on Ona
secure cloud environments
Announced
Deal Status
not yet closed
equity & debt combined
Cursor goes to SpaceX, Ona goes to OpenAI: the AI coding market is consolidating into three vertically integrated stacks (Anthropic and Claude Code, OpenAI and Codex, xAI and Cursor) almost overnight. The independent middle layer of the market is disappearing fast.
SpaceX’s Stock Becomes the Most Useful Tool in Musk’s Toolbox
Peak Share Price
vs. USD 135 IPO price
USD 86.2B
IPO Proceeds
with greenshoe exercised
4th
Market Cap Rank
in the United States
by 2030
A stock that can be spent as fast as it appreciates is a different kind of asset than one held for dividends. SpaceX has turned its public listing into an acquisition engine inside of a week. Expect more deals, not fewer, while the share price holds.
Anduril Wins a US Fighter Jet Program, Something No Startup Has Done in 50 Years
Program
semi-autonomous drone fighter
2 years
Timeline
prototype to production
150/yr
Arsenal-1 Capacity
with room to scale
Europe's largest fintech
Anduril did not win this contract on a better pitch deck. It won it by building the factory before the order existed. That sequencing, capacity before contract, is the single biggest tell that this is not a typical defense-tech story, and it is the reason the FQ-44 win is being read across the industry as a structural shift, not a one-off.
DeepSeek Raises USD 7.4B and Admits, in the Fine Print, That Its Real Problem Is People
Raise
new funding round
>USD 50B
Valuation
post-money
Anti-poach clause
Key Term
on engineering talent
value above the model layer
Capital is not the binding constraint in frontier AI anymore; people are. DeepSeek’s anti-poach clause is the cleanest evidence yet that the war for AI talent has moved ahead of the war for AI capital, at least in China, and that the Big Three are setting the pace.
Thoma Bravo Hands Medallia to Its Lenders, Writes a USD 5B Check to Zero
Write-down
Thoma Bravo equity to zero
USD 6.4B
Original Purchase
in 2021
USD 150M
New Capital
AI pivot, new ownership
prediction market space
Medallia is not an isolated mistake; it is a marker. Every LP holding 2020-2021 vintage software buyouts should be asking how many more of these are quietly sitting at cost on a general partner’s books, waiting for a moment this public to force the recognition.
Private Markets Outlook
This week answered a question the market has been asking since SpaceX priced its IPO: what happens to a freshly listed stock that pops 19% on day one. The answer, at least for SpaceX, is that it becomes acquisition currency almost immediately. The Cursor deal is the clearest evidence yet that the AI coding market is consolidating into a small number of vertically integrated stacks, and that the price of staying independent in this market is falling fast.
The Anthropic export ban is the more consequential story of the week for anyone holding pre-IPO AI exposure, not because it threatens Anthropic's survival, but because it establishes a precedent: frontier AI capability can now be restricted by export control authority, the same regulatory tool historically reserved for weapons and dual-use hardware. The G7 reaction, and the sovereign AI capital it is already unlocking in Europe, suggests this precedent will outlive the specific dispute that created it.
Underneath the AI headlines, the same discipline applies as ever. DeepSeek's anti-poach clause is a tell about where the real scarcity sits in this cycle (it is not capital). Thoma Bravo's Medallia write-down is a reminder that the 2020-2021 vintage of software buyouts still has more bad news to clear. And Anduril's production contract is proof that a defense startup can out-execute legacy primes when it builds the factory before it needs the factory. None of these stories are isolated. They are all the same story: capital is moving fast toward whoever can demonstrate real distribution, real infrastructure, and real execution, and away from everyone else.
Goldbach Capital is the private markets arm of Alpen Partners, your FINMA-licensed Swiss independent asset manager and family office. We give qualified investors curated access to pre-IPO equity, private credit, and alternative investments through direct deals, pooled vehicles, and select third-party manager partnerships.